Illinois-based pharmaceuticals major Abbott Friday said it is acquiring Piramal Healthcare's formulations business for $3.72 billion, to make the combined entity one of the largest players in the country's generic drugs market. view full article..
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment